Cell and tissue research · 2019 · Review · PMID 30915550
Explore the library
Preclinical evidenceSynthetic pentadecapeptide (15 amino acids)
BPC-157
BPC-157 is a synthetic 15-amino-acid peptide described in the literature as related to a gastric protective protein. It is studied mainly in experimental injury models and is not an approved repair treatment.
Also indexed as: Body Protection Compound 157 · PL 14736
A clear starting point
BPC-157 is a synthetic 15-amino-acid peptide described in the literature as related to a gastric protective protein. It is studied mainly in experimental injury models and is not an approved repair treatment.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
Repair / angiogenesis
BPC-157 is a synthetic 15-amino-acid peptide described in the literature as related to a gastric protective protein. It is studied mainly in experimental injury models and is not an approved repair treatment.
- Targets & processes
- Repair / angiogenesis
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Tendon, ligament, muscle and gastrointestinal injury models.
What this does not establish
A review of predominantly rodent studies cannot establish healing benefits in people. Small human reports do not replace adequately controlled trials.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
FDA identifies potential immunogenicity and peptide-impurity risks and insufficient human safety information. Long-term effects and interactions are unknown.
Contraindications & cautions
Not an exhaustive contraindication review. FDA identifies potential immunogenicity and peptide-impurity risks and insufficient human safety information. Long-term effects and interactions are unknown.
Medication & supplement interactions
Interaction information is incomplete. FDA identifies potential immunogenicity and peptide-impurity risks and insufficient human safety information. Long-term effects and interactions are unknown.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.